CLEVELAND, Ohio — When we hear that a friend has breast cancer, we know they’re in for a rough patch but will probably be fine in the end. The reaction is very different if the diagnosis is aggressive ...

The addition of CDK4/6 inhibitors to endocrine therapy has changed the standard of care for patients with high-risk ...

Exploring the safety challenges, training gaps, and key protocols associated with administering chemotherapy through nontraditional routes outside dedicated oncology settings.

Chemotherapy faces a fundamental problem: The same drugs powerful enough to kill cancer cells can also damage healthy tissue. UC Irvine researchers are trying to change that equation by putting a ...

Results from the phase 3 PAPILLON study show that first-line amivantamab plus carboplatin-pemetrexed ...

Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung ...

Perioperative durvalumab plus FLOT reduced mortality versus FLOT alone in 948 patients, yielding 2-year OS 76% versus 70% and ...

A study in mice and human tissue suggests psilocybin protects against peripheral neuropathy, a common side effect of chemotherapy. The findings are so promising that researchers are starting a mid-sta ...

Chemotherapy for stomach cancer can help slow the disease’s growth and control symptoms. However, it may cause some side effects. People with stomach cancer have cells in their stomach that grow ...

Becky Jones is among more than 40 people taking legal action against a hospital trust.

Amivantamab plus chemotherapy demonstrates durable benefit with a differentiated approach that dual targets EGFR and MET1Median overall survival reached 34.3 months with the amivantamab-based regimen, ...

Prior authorization, fail-first step therapy, and market consolidation among pharmacy benefit managers (PBMs) are driving up ...